Pharmaceutical powders are typically screened at 12 to 400 mesh (1,680 to 37 microns) depending on the application. Granulation sizing uses coarser mesh in the 12 to 30 mesh range, while fine API and excipient screening requires 100 to 400 mesh for particle size control and de-agglomeration.
Pharmaceutical screening demands precision, traceability, and compliance with current Good Manufacturing Practice (cGMP) regulations. The mesh size directly affects tablet hardness, dissolution rate, content uniformity, and flowability. Incorrect mesh selection can result in failed batches, out-of-spec product, and regulatory findings. ScreenerKing supplies pharmaceutical-grade stainless steel replacement screens with material certificates to support your quality documentation.
Recommended Mesh Sizes by Application
| Material / Application | Mesh Size | Micron Size | Purpose |
|---|---|---|---|
| Wet granulation sizing | 12–20 mesh | 1,680–841 µm | Break wet mass into target granule size |
| Dry granulation / roller compaction sizing | 14–30 mesh | 1,400–595 µm | Size ribbons into granules for compression |
| Excipient safety screening (lactose, MCC) | 20–40 mesh | 841–400 µm | Remove foreign material and agglomerates |
| API powder classification | 60–200 mesh | 250–75 µm | Particle size control for dissolution rate |
| Tablet coating powder screening | 40–80 mesh | 400–180 µm | Remove agglomerates before coating suspension |
| Fine API de-agglomeration | 200–400 mesh | 75–37 µm | Break up agglomerates for blending uniformity |
| Capsule fill powder | 20–60 mesh | 841–250 µm | Ensure flowability and weight uniformity |
| Effervescent granule grading | 10–20 mesh | 2,000–841 µm | Size classification for dissolution control |
| Finished blend check screening | 14–30 mesh | 1,400–595 µm | Final verification before compression or filling |
Factors That Affect Mesh Selection for Pharmaceutical Powders
- Particle size specification: The United States Pharmacopeia (USP) defines particle size classifications that dictate screening requirements. Your mesh selection must produce material within the USP specification for the product monograph.
- Dissolution requirements: Finer particle sizes increase surface area and improve dissolution rate. APIs intended for immediate-release formulations often require finer mesh screening than sustained-release products.
- Flowability: Powders screened too fine may have poor flow characteristics, causing weight variation in tablet presses and capsule fillers. Balance particle size against flow requirements.
- Electrostatic charge: Many pharmaceutical powders develop static charge during screening, causing adhesion to screens and equipment. Grounding, humidity control, and antistatic additives can mitigate this issue.
- Batch-to-batch consistency: Use the same mesh size, screen type, and machine settings for every batch to ensure reproducibility. Document mesh specifications in batch records.
- Cleaning validation: Finer mesh screens are harder to clean and validate. Consider cleaning requirements when selecting mesh size, and use screens that can be fully disassembled and inspected.
Screen Material Recommendations
316 stainless steel is the recommended screen material for pharmaceutical applications. 316 SS provides superior resistance to corrosion from cleaning agents, solvents, acids, and alkaline compounds commonly encountered in pharmaceutical manufacturing. Most cGMP facilities specify 316 SS for all product-contact surfaces.
304 stainless steel is acceptable for dry screening of non-corrosive excipients and granulations where the facility's quality system permits it. 304 SS costs less than 316 SS and performs well in dry environments.
T-430 stainless steel is used in pharmaceutical facilities that require magnetically detectable screens as a foreign body control measure. If a screen wire breaks and enters the product, T-430 fragments can be detected by downstream metal detectors.
ScreenerKing replacement screens are available in 304 SS, 316 SS, and T-430 with material certificates and mesh verification for pharmaceutical documentation requirements.
Equipment Recommendations
- R&D and clinical batches (under 200 lb/hr): ScreenerKing SiftPro 18" — compact, easy to clean, fits in laminar flow hoods and isolators.
- Pilot and small-scale production (200–2,000 lb/hr): ScreenerKing SiftPro 24" or 30" — standard for pharmaceutical batch processing.
- Full-scale production (2,000–10,000 lb/hr): ScreenerKing SiftPro 48 (48") — high-capacity screening for excipients and high-volume APIs.
- Contract manufacturing and large-scale (10,000+ lb/hr): ScreenerKing SiftPro 60 — maximum throughput for large pharmaceutical operations.
Frequently Asked Questions
What mesh size is used for pharmaceutical granulation sizing?
Pharmaceutical granulations are typically sized through 12 to 20 mesh (1,680 to 841 microns) screens after wet or dry granulation. The exact mesh depends on the target granule size for the tablet press or capsule filler. Oversize granules are recycled through the granulator while undersize fines may be re-granulated or blended back.
Do I need 316 stainless steel screens for pharmaceutical applications?
316 stainless steel is strongly recommended for pharmaceutical screening. 316 SS offers superior corrosion resistance to cleaning agents, solvents, and acidic or alkaline APIs. Many facilities require 316 SS for all product-contact surfaces as part of GMP compliance. ScreenerKing offers 316 SS replacement screens in all sizes from 18 to 60 inches.
Can vibratory screeners be validated for pharmaceutical use?
Yes. Round vibratory screeners from ScreenerKing and compatible brands are widely used in cGMP pharmaceutical manufacturing. Validation involves documenting screen mesh verification, IQ, OQ, and PQ. ScreenerKing provides material certificates and screen specifications to support validation documentation.